Committed to the Development of Proprietary Antiviral Peptides and Monoclonal Antibody for Treating Debilitating Infectious Diseases

Welcome to Enzolytics, Inc.

Enzolytics, Inc. is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Enzolytics is committed to developing monoclonal antibody therapy and treating infectious diseases.   Discover More